B&G Foods vs Tootsie Roll Industries
BGS and TR side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BGS and TR compare
Tootsie Roll Industries is the larger company, worth 10 times as much as B&G Foods ($2.9B against $272M).
Tootsie Roll Industries grew revenue faster over the last twelve months (0.20% versus −2.7% for B&G Foods).
Tootsie Roll Industries keeps more of each dollar of sales as profit, with a net margin of 11.4% compared with −4.7% at B&G Foods.
Both pay dividends: B&G Foods yields 17.0% and Tootsie Roll Industries 0.94%.
Tootsie Roll Industries scores higher on the StockData Score (12 against 10 for B&G Foods), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BGS | TR |
|---|---|---|
| Size and price | ||
| Market cap | $272M | $2.9B |
| Share price | $3.35 | $38.02 |
| Change, 1 year | −29.2% | −0.33% |
| Change, 5 years | −89.1% | 37.1% |
| Beta (5Y) | 0.49 | 0.26 |
| Employees | 2,497 | 2,100 |
| StockData Score | ||
| Total score | 10 | 12 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | – | 32.8× |
| P/S | 0.2× (better) | 3.9× |
| P/B | 0.8× (better) | 3.0× |
| EV/EBITDA | 17.8× (better) | 27.4× |
| P/FCF | 2.7× (better) | 53.0× |
| FCF yield | 36.5% (better) | 1.9% |
| Fair value | $13.82 | $25.73 |
| Margin of safety | 75.8% (better) | −47.7% |
| Growth | ||
| Revenue growth (TTM) | −2.7% | 0.20% (better) |
| Revenue growth, 5Y average | −1.5% | 9.2% (better) |
| Net income growth (TTM) | – | −11.5% |
| EPS growth (TTM) | – | −7.9% |
| Profitability | ||
| Gross margin | 21.8% | 33.8% (better) |
| Operating margin | 3.7% | 10.9% (better) |
| Net margin | −4.7% | 11.4% (better) |
| FCF margin | 5.6% | 7.4% (better) |
| Return on equity | −20.4% | 8.9% (better) |
| Return on invested capital | 2.2% | 7.3% (better) |
| Financial health | ||
| Debt / equity | 5.75 (better) | 0.00 |
| Net debt / EBITDA | 15.68 | – |
| Current ratio | 2.84 (better) | 2.67 |
| Altman Z-score | 1.14 | 6.18 (better) |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 17.0% (better) | 0.94% |
| Payout ratio | – | 32.1% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −16.7% | – |
| Shareholder yield | 17.0% (better) | 0.94% |
| Ownership | ||
| Held by institutions | 57.3% | 17.1% |
| Held by insiders | 5.3% | 59.1% |
| Insider net buying, 12 months | −$248K | – |
| Short interest, % of float | 18.4% | – |
Go deeper
- BGS stock overview
- BGS income statement
- BGS valuation and score
- TR stock overview
- TR income statement
- TR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.